Overview
Matthew Ahearne practices practicing medicine in Leicester, United Kingdom.
Mr. Ahearne is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, T-Cell Lymphoma, and B-Cell Lymphoma.
He is actively involved in clinical research, co-authoring 37 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Matthew J. Ahearne
Is Matthew J. Ahearne a top-rated expert for Marginal Zone Lymphoma (MZL)?
MediFind is an objective health platform that identifies experts based on real-world data. Matthew J. Ahearne is classified as an Advanced expert for Marginal Zone Lymphoma (MZL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Matthew J. Ahearne participate in research or clinical trials?
Yes. Matthew J. Ahearne has published 37 articles and abstracts on conditions like Marginal Zone Lymphoma (MZL). You can view a list of Matthew J. Ahearne's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMr. Ahearne isAdvanced. Learn about B-Cell Lymphoma.
- Chronic T-Cell Leukemia (CTCL)Mr. Ahearne isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Marginal Zone Lymphoma (MZL)Mr. Ahearne isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Non-Hodgkin LymphomaMr. Ahearne isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell LymphomaMr. Ahearne isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Prolymphocytic LeukemiaMr. Ahearne isAdvanced. Learn about Prolymphocytic Leukemia.
- T-Cell LymphomaMr. Ahearne isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Adult T-Cell LeukemiaMr. Ahearne isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaMr. Ahearne isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Mr. Ahearne isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Ahearne isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- LeukemiaMr. Ahearne isExperienced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Mr. Ahearne isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- PlasmacytomaMr. Ahearne isExperienced. Learn about Plasmacytoma.
- Severe Acute Respiratory Syndrome (SARS)Mr. Ahearne isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
- Small Lymphocytic Lymphoma (SLL)Mr. Ahearne isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Splenic NeoplasmMr. Ahearne isExperienced. Learn about Splenic Neoplasm.